Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Nothing equivalent to Trump"s Operation warp speed

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Dec 21, 2021 2:25pm

59 Views

Post# 34251523

RE:RE:Nothing equivalent to Trump"s Operation warp speed

The Biden Administration did -- in April 2020 and it supported Paxlovid's development along with others in trial still. And the UN also helped and Pfizer has granted generic versions for rest of world as a treatment under that program. News doesn't always cover these kind of things, but they're always happening.

https://www.nih.gov/research-training/medical-research-initiatives/activ